Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

PHASE3CompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Parkinson's DiseaseParkinson DiseaseDyskinesias
Interventions
DRUG

ropinirole controlled-release (REQUIP CR) for RLS

Trial Locations (69)

2190

GSK Investigational Site, South Weymouth

12205

GSK Investigational Site, Albany

14226

GSK Investigational Site, Amherst

14603

GSK Investigational Site, Rochester

19104

GSK Investigational Site, Philadelphia

19713

GSK Investigational Site, Newark

21075

GSK Investigational Site, Elkridge

22311

GSK Investigational Site, Alexandria

23226

GSK Investigational Site, Richmond

24014

GSK Investigational Site, Roanoke

25301

GSK Investigational Site, Charleston

27103

GSK Investigational Site, Winston-Salem

27516

GSK Investigational Site, Chapel Hill

27607

GSK Investigational Site, Raleigh

28801

GSK Investigational Site, Asheville

30033

GSK Investigational Site, Decatur

30106

GSK Investigational Site, Austell

30912

GSK Investigational Site, Augusta

31901

GSK Investigational Site, Columbus

32611

GSK Investigational Site, Gainesville

33026

GSK Investigational Site, Pembroke Pines

33143

GSK Investigational Site, Miami

33145

GSK Investigational Site, Fort Lauderdale

33410

GSK Investigational Site, Palm Beach Gardens

33486

GSK Investigational Site, Boca Raton

33606

GSK Investigational Site, Tampa

33612

GSK Investigational Site, Tampa

33952

GSK Investigational Site, Port Charlotte

35216

GSK Investigational Site, Birmingham

35294

GSK Investigational Site, Birmingham

36207

GSK Investigational Site, Anniston

48025

GSK Investigational Site, Bingham Farms

49503

GSK Investigational Site, Grand Rapids

49684

GSK Investigational Site, Traverse City

53715

GSK Investigational Site, Madison

60062

GSK Investigational Site, Northbrook

60194

GSK Investigational Site, Hoffman Estates

60611

GSK Investigational Site, Chicago

60637

GSK Investigational Site, Chicago

66160

GSK Investigational Site, Kansas City

75231

GSK Investigational Site, Dallas

75235

GSK Investigational Site, Dallas

77030

GSK Investigational Site, Houston

77081

GSK Investigational Site, Houston

78229

GSK Investigational Site, San Antonio

78756

GSK Investigational Site, Austin

79410

GSK Investigational Site, Lubbock

80304

GSK Investigational Site, Boulder

83702

GSK Investigational Site, Boise

85006

GSK Investigational Site, Phoenix

85351

GSK Investigational Site, Sun City

85712

GSK Investigational Site, Tucson

89109

GSK Investigational Site, Las Vegas

90033

GSK Investigational Site, Los Angeles

92037

GSK Investigational Site, La Jolla

92660

GSK Investigational Site, Newport Beach

93030

GSK Investigational Site, Oxnard

94596

GSK Investigational Site, Walnut Creek

95126

GSK Investigational Site, San Jose

97401

GSK Investigational Site, Eugene

98034

GSK Investigational Site, Kirkland

98101

GSK Investigational Site, Seattle

98405

GSK Investigational Site, Tacoma

06810

GSK Investigational Site, Danbury

50309-1426

GSK Investigational Site, Des Moines

02673

GSK Investigational Site, West Yarmouth

08818

GSK Investigational Site, Edison

45267-0525

GSK Investigational Site, Cincinnati

97504-8456

GSK Investigational Site, Medford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY